Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...

The donation will establish the Lois Pope Neuroscience Research Fund and will add Lorraine's name to the Lois Pope Laboratory ...

Nothing is clicking for a Rangers offense that is so bad, it has made its great pitching staff nearly irrelevant. | Opinion ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

Richter died on Monday, June 2, after a brief illness. A celebration of her life and legacy will be celebrated at a future date.

As part of ALS Awareness Month, the Miami Marlins recognized Lou Gehrig’s legacy and the fight against ALS during a special ...

Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...

Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...